Salomón Páez-García

Salomón Páez-García

Pontificia Universidad Javeriana, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Acta Odontologica Scandinavica
Verified
Journal Article
Open access
PDF file
MBMiguel G. Borda
Miguel G. Borda
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
LMLuisa Fernanda Murcia
Luisa Fernanda Murcia
LVLuis Carlos Venegas-Sanabria
Luis Carlos Venegas-Sanabria
Objective: The objective of this study was to compare the clinical and patient-related outcomes of root canal therapy (RCT) and dental implants (DIs) in managing severe tooth damage, supporting evidence-based treatment decisions. Material and methods: A systematic review was performed in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Six databases were searched: Cochrane Library, Embase, Medline, LILACS, Scopus, and Web of Science. Studies comparing clinical and patient-reported outcomes in adult patients treated with either RCT or DIs were included. The Joanna Briggs Institute Critical Appraisal Checklists were used to assess the risk of bias. Due to significant heterogeneity among studies, meta-analysis was not feasible, and findings were synthesised qualitatively. PROSPERO registration: CRD42024584113. Results: Out of 1,876 initial records, 12 studies met inclusion criteria: 7 cohort studies, 4 case-control studies, and 1 randomised controlled trial. Most studies had low to moderate risk of bias. Both RCT and DIs demonstrated high survival rates, with RCT slightly outperforming DIs in terms of success. Failure rates ranged from 0.7% to 12.0%, with no significant differences between treatments. DIs were associated with a higher frequency of postoperative interventions and complications. Patient-reported outcomes such as pain, satisfaction, and quality of life (QoL) were comparable across both modalities. Conclusion: RCT and DIs both offer viable and effective solutions for restoring severely damaged teeth, with high survival and success rates and low failure rates. Both treatments were also associated with favourable patient-reported outcomes, including minimal pain, high satisfaction, and improved QoL. The decision between treatments should consider clinical factors, patient preferences, cost, accessibility, potential complications, and patient-centred outcomes. Shared decision-making is essential for optimal patient care.

1 November 2025 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
MBMiguel G. Borda
Miguel G. Borda
LVLuis Carlos Venegas‐Sanabria
Luis Carlos Venegas‐Sanabria
MCMarco Canevelli
Marco Canevelli
FLFrancesco Landi
Francesco Landi
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
DADag Aarsland
Dag Aarsland
Introduction: Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia. Methodology: We conducted a systematic review to investigate which adverse outcomes in 65 years or older adults with dementia are influenced by frailty. A comprehensive search was conducted across three databases—MEDLINE, EMBASE, and Cochrane—to identify relevant studies addressing this research question as of November 2024. Studies were considered for inclusion if they were observational studies or clinical trials involving individuals with dementia, assessed frailty within this population, and documented adverse health outcomes. Two independent and blinded researchers performed screening, data extraction, and risk of bias assessment. PROSPERO register CRD42024543327. Results: Our search identified 5891 articles, from which 12 were included after screening and eligibility assessment ( n = 172,025 participants). Alzheimer's disease was the most studied type of dementia, and the prevalence of frailty ranged from 8% to 65.9%. The reported adverse outcomes associated with frailty in patients suffering from dementia were mortality, institutionalization, functional and cognitive decline, neuropsychiatric symptoms, reduced quality of life, caregiver burden, and hospitalization. Discussion: Understanding frailty in older adults with dementia may inform improved care strategies. Our findings suggest that higher levels of frailty are associated with an increased risk of adverse health outcomes.

22 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DHDaniel Hernandez-Triana
Daniel Hernandez-Triana
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
AMAlexandre Mena
Alexandre Mena
MGMar Gimeno
Mar Gimeno
MLMaria Alejandra Soto Leal
Maria Alejandra Soto Leal
MBMiguel G. Borda
Miguel G. Borda
Background: Parkinson’s disease (PD) and frailty frequently co-occur and may interact bidirectionally through shared mechanisms of aging biology, mitochondrial dysfunction, inflammation, and reduced physiological reserve. Objective: We aimed to synthesize current evidence on prevalence, directionality, clinical overlap, adverse outcomes, and management implications of the PD–frailty nexus. Methods: A narrative review of epidemiologic, cohort, and interventional studies was performed, examining frailty in PD and PD risk in prefrail/frail populations, plus trials of multimodal interventions. Results: Frailty is common in PD, affecting approximately one-third of patients overall and becoming more prevalent as the disease advances. It independently predicts falls, cognitive decline, hospitalization, institutionalization, and mortality. Large cohorts suggest prefrailty/frailty is associated with incident PD risk, supporting a potential bidirectional association rather than direct causation. Diagnostic complexity arises because PD motor and non-motor features overlap with frailty constructs, risking misclassification. Management based on Comprehensive Geriatric Assessment (CGA) enhances personalized, multidisciplinary care. Exercise, particularly combined aerobic and resistance training reduces frailty and improves mobility, postural control, and quality of life. Complementary nutritional strategies, including muscle-targeted supplementation, can further strengthen rehabilitation outcomes, while careful attention to social determinants and polypharmacy remains essential to optimizing overall health and functional independence. Conclusions: Frailty is best understood as a clinical marker of vulnerability within PD and a correlate of more adverse trajectories rather than a proven causal determinant. Systematic frailty assessment integrated into PD care may help refine prognosis, individualize treatment, and support efforts to preserve independence. Priorities include PD-adapted frailty tools, CGA implementation, and rigorous trials of combined exercise–nutrition programs.

21 April 2025 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
CCCarlos Cano-Gutierrez
Carlos Cano-Gutierrez
Salomón Salazar-LondoñoSalomón Salazar-Londoño
Salomón Salazar-Londoño
FBFelipe Botero‐Rodriguez
Felipe Botero‐Rodriguez
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
SGSalomón Giraldo
Salomón Giraldo
CDCol‐ Dlb
Col‐ Dlb
Background: Dementia research in Latin America (LA) has primarily focused on Alzheimer's Disease and Frontotemporal Dementia, while Lewy body dementia (LBD) has been largely forgotten.Objective: We aimed to review the available evidence on LBD in LA, offering a comprehensive perspective for understanding the lack of reports and the unique challenges and characteristics of this region.Methods: We carried out a scoping review in databases: PubMed, EMBASE, LILACS, and Web of Science. Original studies that included participants with LBD were analyzed.Results: Of the 1388 studies identified, 70 met the inclusion criteria for this review. Among them, 63 were cross‐sectional studies, three were cohort studies, two followed a case–control methodology, and only two were non‐randomized clinical trials. These studies primarily examined clinical manifestations, risk factors, neuropsychiatric and non‐motor symptoms, as well as cognitive impairment and its assessment in LBD within LA. Regarding geographical distribution, 52 studies were conducted in Brazil, seven in Argentina, the rest in Peru, Mexico, Colombia, Cuba, and Chile.Conclusions: LBD research in LA is underrepresented, with most studies being cross‐sectional, few utilizing a longitudinal design, and only two clinical trials, both of which lack rigorous methodology. Challenges include weak study designs, high heterogeneity, limited trials, and unclear differentiation within the LBD spectrum. Addressing these gaps requires increasing awareness, strengthening research capacity, securing funding, and fostering international collaboration.

8 April 2025 in Neurology
Verified
Journal Article
Closed access
Valentina VelascoValentina Velasco
Valentina Velasco
ARAndrés Ricaurte-Fajardo
Andrés Ricaurte-Fajardo
KTKiara Torres-Tello
Kiara Torres-Tello
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
GCGabriel Castellanos-Castañeda
Gabriel Castellanos-Castañeda
JAJuan Carlos Acevedo-González
Juan Carlos Acevedo-González

15 December 2025 in Exploration of Neuroprotective Therapy
Verified
Journal Article
Open access
PDF file
Salomón Páez-GarcíaSalomón Páez-García
Salomón Páez-García
DHDaniel Hernandez-Triana
Daniel Hernandez-Triana
FELIPE ESPARZA SALAZARFELIPE ESPARZA SALAZAR
FELIPE ESPARZA SALAZAR
GBGeorge E. Barreto
George E. Barreto
MRMaría Cruz Rodríguez-Oroz
María Cruz Rodríguez-Oroz
MBMiguel G. Borda
Miguel G. Borda
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, in which gut microbiota alterations have emerged as a potential pathogenic factor, causing disruption of the brain-gut-microbiota (BGM) axis. Recent evidence supports the role of BGM axis disruption in enhancing neuroinflammation, alpha-synuclein (α-syn) aggregation, and dopaminergic neurodegeneration. Emerging therapeutic strategies targeting dysbiosis, such as probiotics and fecal microbiota transplantation (FMT), have become a new focus of investigation for PD treatment. Proposed mechanisms include modulation of immune responses, enhancement of intestinal barrier integrity, production of neuroactive metabolites such as short-chain fatty acids, and reduction of oxidative stress. This narrative review summarizes current evidence on probiotics as a therapeutic strategy in PD. By analyzing data from randomized controlled trials and preclinical studies, we highlight the beneficial effects of probiotics in improving motor and non-motor symptoms of PD, including constipation, depression, and anxiety. Strains such as Lactobacillus plantarum PS128 and Bifidobacterium animalis Probio-M8 show particular promise. Although probiotics have demonstrated a favorable safety profile and potential as an adjunctive therapy for PD, future research should focus on standardized protocols, biomarker identification, and exploration of combined microbiota-targeted strategies.